Clinical Trial: Evaluate Bioequivalence of Micafungin (50mg/Vial)
Study Status: Completed
Recruit Status: Completed
Condition: A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of
Study Type: Interventional
Official Title: A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Micafungin (50 mg/Vial) After Intravenous Infusion of 50 mg Micafungin in Healthy Volunteers Under
Brief Summary:
A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of micafungin (50 mg/vial) after intravenous infusion of 50 mg micafungin in healthy volunteers under fasting conditions
Read more